Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Protection certificate |
| Status | ST | Not pending/lapsed |
| 21 | DE file number | DAKZ | 12 2014 000 036.0 |
| Use | VZ | Medicinal products |
| 95 | Product name | TIEZ | Dexlansoprazol ( (R)-2-([3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl)-1H-benzimidazol ) oder seine Salze |
| 54 | Title of basic patent | TIGZ | KRISTALLINE FORM DES (R)-2-[[[3-METHYL-4-(2,2,2-TRIFLUORETHOXY)-2-PYRIDINYL]METHYL]SULFINYL]-1H-BENZIMIDAZOLS |
| 51 | IPC main class | ICM
(ICMV) | C07D 401/12 (2006.01) |
| 51 | IPC secondary class(es) | ICS
(ICSV) | A61K 31/44 (2006.01), A61P 1/04 (2006.01) |
| 94 | Start of term of protection | LB | Jun 16, 2020 |
| 94 | End of term of protection | LE | Jun 15, 2025 |
| 22 | DE application date | DAT | Mar 20, 2014 |
| Date of publication of application for a certificate | OT | May 8, 2014 |
| Date of publication of grant of certificate | PET | Sep 1, 2016 |
| 71/73 | Applicant/owner | INH | Takeda Pharmaceutical Company Limited, 1-1, Doshomachi 4-chome, Chuo-ku, 541-0045 Osaka, JP |
| 74 | Representative | VTR | dompatent von Kreisler Selting Werner - Partnerschaft von Patentanwälten und Rechtsanwälten mbB, 50667 Köln, DE |
| Address for service | | dompatent von Kreisler Selting Werner - Partnerschaft von Patentanwälten und Rechtsanwälten mbB, 50667 Köln, DE |
| Patent division in charge | | 44 |
| 68 | DE file number of basic patent | GAKZ | 600 38 481.0 |
| 68 | EP file number of basic patent | GEAKZ | 00 93 7235.0 |
| 43 | Date of first publication | EVT | May 8, 2014 |
92
92
92
| Domestic authorisation | GIS
GIN
GIT
| Bundesinstitut für Arzneimittel und Medizinprodukte
87192.00.00
2013-11-18
|
92
92
92
| Domestic authorisation | GIS
GIN
GIT
| Bundesinstitut für Arzneimittel und Medizinprodukte
87193.00.00
2013-11-18
|
92
92
92
| Domestic authorisation | GIS
GIN
GIT
| Bundesinstitut für Arzneimittel und Medizinprodukte
87195.00.00
2013-11-18
|
92
92
92
| Domestic authorisation | GIS
GIN
GIT
| Bundesinstitut für Arzneimittel und Medizinprodukte
87194.00.00
2013-11-18
|
93
93
93
93
| EU authorisation | GES
GEC
GEN
GET
| Läkemedelsverket – Medical Products Agency
Schweden
47913
2013-09-19
|
93
93
93
93
| EU authorisation | GES
GEC
GEN
GET
| Läkemedelsverket – Medical Products Agency
Schweden
47912
2013-09-19
|
93
93
93
93
| EU authorisation | GES
GEC
GEN
GET
| Läkemedelsverket – Medical Products Agency
Schweden
47914
2013-09-19
|
93
93
93
93
| EU authorisation | GES
GEC
GEN
GET
| Läkemedelsverket – Medical Products Agency
Schweden
47911
2013-09-19
|
| Date of the first transfer into DPMAregister | EREGT | May 8, 2014 |
| Date of the (most recent) update in DPMAregister | REGT | Jul 24, 2025
(Show all update days)(Hide all update days)- Jul 24, 2025
- Procedures: Administrative procedure, IP right lapsed through expiry of term of protection, 15.06.2025: changed
- Jun 17, 2025
- Status: changed
- Procedures: Administrative procedure, IP right lapsed through expiry of term of protection, 15.06.2025: new
- Aug 5, 2024
- St.36: changed (technical change)
- May 8, 2014
- Date of the first transfer into DPMAregister
|
